311 related articles for article (PubMed ID: 11412048)
1. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.
Buchbinder R; Forbes A; Hall S; Dennett X; Giles G
Ann Intern Med; 2001 Jun; 134(12):1087-95. PubMed ID: 11412048
[TBL] [Abstract][Full Text] [Related]
2. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
3. Malignancy in patients with inflammatory myopathy.
Buchbinder R; Hill CL
Curr Rheumatol Rep; 2002 Oct; 4(5):415-26. PubMed ID: 12217247
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan.
Weng MY; Lai EC; Kao Yang YH
Rheumatology (Oxford); 2019 Nov; 58(11):1935-1941. PubMed ID: 30903193
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K
J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322
[TBL] [Abstract][Full Text] [Related]
6. The overall and temporal association of cancer with polymyositis and dermatomyositis.
Zantos D; Zhang Y; Felson D
J Rheumatol; 1994 Oct; 21(10):1855-9. PubMed ID: 7837150
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.
Tan JA; Roberts-Thomson PJ; Blumbergs P; Hakendorf P; Cox SR; Limaye V
Int J Rheum Dis; 2013 Jun; 16(3):331-8. PubMed ID: 23981756
[TBL] [Abstract][Full Text] [Related]
8. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.
Hill CL; Zhang Y; Sigurgeirsson B; Pukkala E; Mellemkjaer L; Airio A; Evans SR; Felson DT
Lancet; 2001 Jan; 357(9250):96-100. PubMed ID: 11197446
[TBL] [Abstract][Full Text] [Related]
9. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.
Oh TH; Brumfield KA; Hoskin TL; Stolp KA; Murray JA; Bassford JR
Mayo Clin Proc; 2007 Apr; 82(4):441-7. PubMed ID: 17418072
[TBL] [Abstract][Full Text] [Related]
10. Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis.
Callen JP
Rheum Dis Clin North Am; 1994 Nov; 20(4):943-53. PubMed ID: 7855330
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis-dermatomyositis and malignant lesions: does an association exist?
Lakhanpal S; Bunch TW; Ilstrup DM; Melton LJ
Mayo Clin Proc; 1986 Aug; 61(8):645-53. PubMed ID: 3724244
[TBL] [Abstract][Full Text] [Related]
12. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
13. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.
Sigurgeirsson B; Lindelöf B; Edhag O; Allander E
N Engl J Med; 1992 Feb; 326(6):363-7. PubMed ID: 1729618
[TBL] [Abstract][Full Text] [Related]
14. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
15. Incidence of malignancies in biopsy-proven inflammatory myopathy.
Kannan MA; Sundaram C; Uppin M; Mridula R; Jabeen SA; Borgohain R
Neurol India; 2013; 61(2):152-5. PubMed ID: 23644314
[TBL] [Abstract][Full Text] [Related]
16. [Myositis associated with tumors].
András C; Ponyi A; Constantin T; Csiki Z; Illés A; Szegedi G; Dankó K
Magy Onkol; 2002; 46(3):253-9. PubMed ID: 12368921
[TBL] [Abstract][Full Text] [Related]
17. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
19. The risk of cancer in patients with connective tissue diseases but without dermatomyositis or polymyositis: A multicenter cohort study conducted over 15 years in China.
Xu W; Guo H; Liu Z; Chen C; Lei CC
Immunol Lett; 2016 Sep; 177():70-4. PubMed ID: 27474413
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.
Wakata N; Kurihara T; Saito E; Kinoshita M
Int J Dermatol; 2002 Nov; 41(11):729-34. PubMed ID: 12452993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
